Our comments; they would not be doing this unless people were buying. Additionally, people would not be buying if the didn't think it would work. Another global supply chain shortened.
"The drug had been in short supply earlier in March, according to news reports, but Mylan and another generic drug firm, Israel-based Teva, are both ramping up production."
Read Our Latest News
Do you like this post?